Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anticancer drug-induced nephrotoxicity].

Corinne Isnard-Bagnis1, Bruno Moulin, Vincent Launay-Vacher

  • 1Service de Néphrologie, Hôpital Pitié-Salpêtrière, 83, Boulevard de l'Hôpital, 75013 Paris, France. corinne.bagnis@psl.ap-hop-paris.fr

Nephrologie & Therapeutique
|August 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for acquisition of SARS-CoV-2 Omicron variant among a prospective cohort of French Healthcare Workers: impact of hybrid immunity.

Scientific reports·2026
Same author

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

PloS one·2026
Same author

Association of Complement Genetics with Outcomes in IgA Nephropathy.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Effects of Microplastics and Nanoplastics on the Kidneys.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Correction: Acceptability of Health Information Technology by Health Care Professionals: Where We Are Now and How We Can Fill the Gap.

Journal of medical Internet research·2026
Same author

Acceptability of Health Information Technology by Health Care Professionals: Where We Are Now and How We Can Fill the Gap.

Journal of medical Internet research·2025
Same journal

Nutritional monitoring in peritoneal dialysis: Biological and non-biological markers and dietary strategies

Nephrologie & therapeutique·2026
Same journal

Supporting patients and family members facing treatment choices in chronic kidney disease: What do professionals think of the decision aids used? - Professionals’ views on treatment decision support tools

Nephrologie & therapeutique·2026
Same journal

From Turing to ChatGPT: The origins and transformations of medical artificial intelligence

Nephrologie & therapeutique·2026
Same journal

Analysis of the predictive value of serum Cys-C and IL-6 levels for acute kidney injury in patients with acute respiratory distress syndrome.

Nephrologie & therapeutique·2026
Same journal

Navigating pain in chronic kidney disease: Overcoming inertia!

Nephrologie & therapeutique·2026
Same journal

Kidney health for all: caring for people, protecting the planet1.

Nephrologie & therapeutique·2026
See all related articles

Anticancer drugs can cause kidney damage (nephrotoxicity) due to their narrow therapeutic index. Managing drug doses and monitoring kidney function are crucial for cancer patients undergoing treatment.

Area of Science:

  • Oncology
  • Nephrology
  • Pharmacology

Context:

  • Anticancer drugs, particularly those with a narrow therapeutic index, frequently cause nephrotoxicity.
  • Cancer patients often have pre-existing or treatment-induced renal impairment, increasing vulnerability.
  • A bidirectional relationship exists: malignancies increase renal risk, and renal disease increases malignancy risk, especially post-transplant.

Purpose:

  • To highlight the inherent nephrotoxicity of anticancer agents.
  • To emphasize the challenges in managing drug dosages in cancer patients with compromised renal function.
  • To underscore the need for pharmacokinetic and pharmacodynamic modulation of these drugs.

Summary:

  • Nephrotoxicity is a significant adverse effect of anticancer drugs, often dose-limiting.

Related Experiment Videos

  • Cancer patients' compromised renal function complicates treatment, necessitating careful drug management.
  • Current prevention strategies include dose reduction and vigilant renal screening.

    • Impact:

    • Improved understanding of anticancer drug nephrotoxicity mechanisms.
    • Potential for optimized therapeutic strategies to enhance drug tolerance in cancer patients.
    • Enhanced patient outcomes through better management of renal function during cancer therapy.